Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 60 of 60 entries
View as:

Real-time fMRI for the Treatment of Aggressive Behavior in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT02563145 Org: User:
Start: 10/31/15 End: 07/31/19 Due: 07/31/20

Neurobiological Mechanisms of Chess as an Add-On Treatment Against SUD

Phase: N/A Priority: Normal
NCT ID: NCT04057534 Org: User:
Start: 04/01/20 End: 11/17/23 Due: 11/17/24

Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT02051387 Org: User:
Start: 01/31/13 End: 08/31/17 Due: 08/31/18

Training of Neural Responding in BPD

Phase: N/A Priority: Normal
NCT ID: NCT02866110 Org: User:
Start: 10/31/16 End: 07/31/18 Due: 07/31/19

Evaluation Study of New Compounds With Potential Use in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00916201 Org: User:
Start: 01/31/25 End: 01/31/25 Due: 01/31/26

Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids

Phase: N/A Priority: Normal
NCT ID: NCT02487381 Org: User:
Start: 04/30/15 End: 08/31/15 Due: 08/31/16

Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

Phase: N/A Priority: Normal
NCT ID: NCT02291536 Org: User:
Start: 02/28/14 End: 12/31/14 Due: 12/31/15

Me and the Others: Expectations and Evaluation of Social Relationships

Phase: N/A Priority: Normal
NCT ID: NCT03764566 Org: User:
Start: 01/31/20 End: 03/31/21 Due: 03/31/22

Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study

Phase: N/A Priority: Normal
NCT ID: NCT02492074 Org: User:
Start: 12/31/24 End: 05/31/25 Due: 05/31/26

Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

Phase: N/A Priority: Normal
NCT ID: NCT00224315 Org: User:
Start: 11/30/03 End: 09/30/06 Due: 09/30/07